Skip to content

XBIO REPORT

FREE WEEKLY BIOTECH STOCK CATALYST REPORTS
CONTACT

Actinium Pharmaceuticals Receives Two Patent Allowances Spanning Its Actimab-A and Iomab-ACT Programs

May 29, 2026

NYSEAMERICAN: $ATNM

Source: Read More

Announcements, New Patent

$ATNM, Actimab-A, Iomab-ACT, pr-newswire

© XBioReport.com

Disclaimer: This site is for information only. Not investment advice.

Get FREE Biotech Stock Catalyst Reports

Email

Notify me about related content and special offers.

Yes No

If you opt in above, we use this information to send related content, discounts, and other special offers.